Who owns the PHARMION trademark?

The PHARMION trademark is owned by Celgene Corporation.

What class is the PHARMION trademark registered in?

The PHARMION trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for PHARMION?

The USPTO serial number for PHARMION is 76048242.

What is the registration number for PHARMION?

PHARMION is registered under USPTO registration number 2575256.

Sealvo

Home Search: PHARMIONPHARMION #76048242

Back

Updated Oct 19, 2026·14 searches this week

View on USPTO TSDR Find similar marks

PHA

USPTO Trademark Record

ABANDONED

PHARMION

SN 76048242·Reg 2575256·Filed May 15, 2000

Owner Celgene Corporation

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PHARMION (Serial No. 76048242), Registration No. 2575256, is a abandoned US trademark filed on May 15, 2000 by Celgene Corporation. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

PHARMION (Reg. #2575256) is an abandoned US trademark that was filed in 2000 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 15, 2000

SERIAL

76048242

REG#

2575256

REGISTERED

Jun 04, 2002

Filing Information

StatusABANDONED

Filing DateMay 15, 2000

Serial Number76048242

Registration No.2575256

Registration DateJun 04, 2002

Status DateDec 16, 2022

Published for OppositionMar 12, 2002

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 AcceptedSection 15 Acknowledged

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 04, 2000

First use in commerce: Feb 04, 2000

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Dec 16, 2022

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jun 04, 2021

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 29, 2015

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jun 27, 2012

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jun 09, 2011

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jun 09, 2011

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

TEAS SECTION 8 & 9 RECEIVED

Jun 07, 2011

TEAS SECTION 8 & 9 RECEIVED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

May 07, 2008

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

ASSIGNED TO PARALEGAL

Apr 29, 2008

ASSIGNED TO PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Apr 29, 2008

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

TEAS SECTION 8 & 15 RECEIVED

Apr 15, 2008

TEAS SECTION 8 & 15 RECEIVED

CASE FILE IN TICRS

Sep 07, 2007

CASE FILE IN TICRS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 20, 2007

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 20, 2007

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jun 04, 2002

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 12, 2002

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Feb 20, 2002

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 06, 2001

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 14, 2001

ASSIGNED TO EXAMINER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 24, 2001

CORRESPONDENCE RECEIVED IN LAW OFFICE

FINAL REFUSAL MAILED

Aug 21, 2001

FINAL REFUSAL MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 21, 2001

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION MAILED

Nov 20, 2000

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Nov 09, 2000

ASSIGNED TO EXAMINER

Nov 03, 2000

ASSIGNED TO EXAMINER

Nov 01, 2000

ASSIGNED TO EXAMINER

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

Oct 20, 2000

UNRESPONSIVE/DUPLICATE PAPER RECEIVED

Other Marks by Celgene Corporation

Additional USPTO filings from the same owner.

BOL

BOLDER SCIENCE

88303506

Celgene Corporation

REGISTERED

BOL

BOLDER SCIENCE

88312560

Celgene Corporation

REGISTERED

R2R

R2 REVLIMID/RITUXIMAB

88655362

Celgene Corporation

REGISTERED

R²

88655182

Celgene Corporation

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

PHA

PHARMION

76382469

Pharmion Corporation

ABANDONED

Other Marks by Camille M. Miller

Additional USPTO filings handled by the same attorney of record.

BEA

BEACH PRIDE

87381614

REGISTERED

DAN

DANSKO

78974374

REGISTERED

LOG

LogoMark

73573385

REGISTERED

POW

POWER HALF HOUR

76286305

REGISTERED

PHARMION

Run a conflict check

Other Marks by Celgene Corporation

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Camille M. Miller

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company